Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
To assess the effects of treatment with XOMA 052 on beta-cell function and insulin production
in subjects with well-controlled Type 1 diabetes. The safety, tolerability, and
pharmacokinetics (PK) of XOMA 052 will also be assessed.